Amsterdam, Netherlands

Martine E D Chamuleau

USPTO Granted Patents = 5 

Average Co-Inventor Count = 11.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Martine E D Chamuleau: Innovating in Cancer Treatment

Introduction

Martine E D Chamuleau is a notable inventor based in Amsterdam, NL, recognized for his contributions to the field of biomedical engineering and oncology. With a total of four patents to his name, his work focuses on the development of innovative antibody therapies for cancer treatment.

Latest Patents

Chamuleau’s recent patents include groundbreaking inventions related to anti-CD37 and anti-CD20 antibodies. One of his significant patents describes anti-CD37 antibodies featuring modifications in the Fc-region of human IgG to enhance Fc-Fc interactions. This invention positions the antibodies for use as a medicament in conjunction with anti-CD20 antibodies, improving therapeutic efficacy. Furthermore, the patent pertains to a new composition of these antibodies, specifically designed for the treatment of cancer and other diseases, making it a pivotal contribution to medical science.

Another noteworthy patent developed by Chamuleau involves bispecific anti-CD37 antibodies. These antibody molecules are engineered to bind to different epitopes of the human CD37 antigen, boasting enhanced Fc-Fc interactions. This innovation not only contributes to a better understanding of targeted therapies but also offers new avenues for the treatment of cancer and other diseases. Chamuleau’s work in creating pharmaceutical compositions containing these bispecific antibodies underscores his commitment to advancing cancer therapy.

Career Highlights

Martine E D Chamuleau has made significant strides in his career, particularly in his role at Genmab Holding B.V., a leading biotechnology company specializing in the creation of differentiated antibody therapeutics for the treatment of cancer. His expertise in antibody engineering and his unwavering pursuit of innovation have positioned him as a respected figure in the industry.

Collaborations

Throughout his career, Chamuleau has collaborated with esteemed colleagues, including Simone Oostindie and Frank Beurskens. These collaborative efforts highlight the importance of teamwork in advancing scientific research and developing new therapeutic strategies.

Conclusion

Martine E D Chamuleau continues to make a remarkable impact in the field of cancer treatment through his innovative patents and collaborations. His dedication to enhancing therapeutic options for patients exemplifies the vital role of inventors in the advancement of medical science. As research continues to evolve, Chamuleau's contributions remain pivotal in the quest for effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…